TopFunds

Mettler Toledo

NYSE: MTD

Stock price

1529.46 USD

(+0%) TODAY

Life Sciences Tools & ServicesMedical - Diagnostics & Research
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
12.5
14.2
14.2
19.9
22.5
24.9
32.8
38.4
35.9
40.5
42.1
12.9%
02Free cash flow per share
12.2
11.8
14.7
16.4
20.3
26.1
34.2
32.5
39.2
40.5
41.1
12.9%
03Dividends per share
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
PROFIT AND LOSS STATEMENT
05Revenue
2,395
2,508
2,725
2,936
3,009
3,085
3,718
3,920
3,788
3,872
4,026
5.3%
06% Change
-
-
-
-
-
-
-
-
-
-
-
5.3%
07Cost of revenue
(1,062)
(1,116)
(1,192)
(1,299)
(1,317)
(1,341)
(1,610)
(1,678)
(1,619)
(1,620)
(1,710)
4.9%
08Gross profit
1,334
1,393
1,533
1,637
1,692
1,744
2,109
2,242
2,169
2,253
2,316
5.7%
09% Margin
55.7%
55.5%
56.3%
55.8%
56.2%
56.5%
56.7%
57.2%
57.3%
58.2%
57.5%
56.6% A
10Operating expenses
(819.9)
(852.6)
(923.2)
(953.9)
(963.1)
(960.3)
(1,114)
(1,116)
(1,089)
(1,126)
(1,198)
3.9%
11% of Revenue
(34.2)%
(34)%
(33.9)%
(32.5)%
(32)%
(31.1)%
(30)%
(28.5)%
(28.8)%
(29.1)%
(29.8)%
(31.3)% A
12Operating Income
513.7
540.2
609.9
683
728.4
784
994.7
1,126
1,080
1,127
1,119
8.1%
13Income tax expense
(110.6)
(119.8)
(198.2)
(139.2)
(120.3)
(146)
(180.4)
(198.1)
(184.9)
(174.1)
(179.7)
5%
14Net Income
352.8
384.4
376
512.6
561.1
602.7
769
872.5
788.8
863.1
869.2
9.4%
15% Margin
14.7%
15.3%
13.8%
17.5%
18.7%
19.5%
20.7%
22.3%
20.8%
22.3%
21.6%
18.8% A
16Shares Outstanding
28.3
27
26.4
25.8
25
24.2
23.5
22.7
22
21.3
20.7
(3.1)%
17EPS Basic
12.8
14.5
14.6
20.3
22.8
25.2
33.3
38.8
36.1
40.7
42.2
12.7%
18EPS Diluted
12.5
14.2
14.2
19.9
22.5
24.9
32.8
38.4
35.9
40.5
42.1
12.9%
19EBITDA
577.7
609
686
767.7
817.1
882.8
1,103
1,239
1,201
1,250
1,244
8%
% Margin
24.1%
24.3%
25.2%
26.2%
27.2%
28.6%
29.7%
31.6%
31.7%
32.3%
30.9%
28.3% A
20Net Interest Income (expense)
(27.5)
(28)
(32.8)
(34.5)
(37.4)
(38.6)
(43.2)
(55.4)
(77.4)
(74.6)
(68.5)
9.6%
21Net Debt / EBITDA
0.8
1.2
1.2
1.1
1.3
1.4
1.5
1.6
1.8
1.7
1.8
1.4 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
98.9
158.7
148.7
178.1
207.8
94.3
98.6
96
69.8
59.4
66.9
(3.8)%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
411.4
455
528.6
535.5
566.3
593.8
647.3
709.3
663.9
687.1
778.2
6.6%
25Other current assets
70.6
61.1
74
63.4
61.3
71.2
108.9
128.1
110.6
105.2
130.3
6.3%
26Inventory
214.4
222
255.4
268.8
274.3
297.6
414.5
441.7
385.9
342.3
387.2
6.1%
27Total Current Assets
795.3
896.8
1,007
1,046
1,110
1,057
1,269
1,375
1,230
1,194
1,363
5.5%
Non-Current Assets
28Net property, plant & equipment
517.2
563.7
668.3
717.5
748.7
798.9
799.4
778.6
803.4
770.3
845.6
5%
29Long-term investments
-
-
-
-
-
-
2.1
6.9
-
0.4
-
(42.7)%
30Other non-current assets
646.8
706.3
874.8
855.5
931
958.8
1,256
1,332
1,322
1,275
1,504
8.8%
31Total Non-Current Assets
1,164
1,270
1,543
1,573
1,680
1,758
2,057
2,117
2,125
2,046
2,350
7.3%
Total Assets
1,959
2,167
2,550
2,619
2,789
2,815
3,327
3,492
3,356
3,240
3,713
6.6%
LIABILITIES
Current Liabilities
32Accounts payable
142.1
146.6
167.6
196.6
185.6
175.8
272.9
252.5
210.4
215.8
266.6
6.5%
33Short-term debt
14.5
19
19.7
49.7
55.9
50.3
131.8
135.3
220.7
212.4
99
21.2%
34Other current liabilities
401.6
421.9
502.4
488.1
513.1
614.2
741.9
759.9
749.9
739.9
832.4
7.6%
35Total Current Liabilities
558.2
587.5
689.7
734.4
754.5
840.3
1,147
1,148
1,181
1,168
1,198
7.9%
Non-Current Liabilities
36Long-term debt
575.1
875.1
960.2
985
1,235
1,284
1,669
1,995
1,976
1,919
2,244
14.6%
37Other non-current liabilities
245.5
269.3
352.7
309.3
378.7
407.4
339.7
324.5
348.9
280.1
293.8
1.8%
38Total Non-Current Liabilities
820.7
1,144
1,313
1,294
1,614
1,692
2,009
2,320
2,324
2,199
2,538
12%
39Total Liabilities
1,379
1,732
2,003
2,029
2,369
2,532
3,155
3,468
3,506
3,367
3,736
10.5%
SHAREHOLDERS` EQUITY
40Common stock
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
-
41Retained earnings / (deficit)
2,692
3,066
3,433
3,942
4,499
5,096
5,859
6,727
7,511
8,371
9,238
13.1%
42Accumulated other comprehensive income / (loss)
(266.6)
(355)
(265.4)
(302.4)
(323.7)
(334.9)
(255.2)
(227.2)
(319.8)
(345.9)
(359.2)
3%
43Noncontrolling interests
-
-
-
-
-
-
-
-
-
-
-
-
44Total shareholders' equity
580.5
434.9
547.3
590.1
420.8
282.7
171.4
24.8
(149.9)
(126.9)
(23.6)
-
45Total Liabilities and shareholders' Equity
1,959
2,167
2,550
2,619
2,789
2,815
3,327
3,492
3,356
3,240
3,713
6.6%
46Total Debt
589.6
894
979.8
1,035
1,291
1,335
1,801
2,131
2,196
2,131
2,343
14.8%
47Net Debt
490.7
735.4
831.2
856.6
1,083
1,240
1,702
2,035
2,127
2,072
2,277
16.6%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
352.8
384.4
376
512.6
561.1
602.7
769
872.5
788.8
863.1
869.2
9.4%
49Depreciation & amortization
64
68.8
76.1
84.7
88.7
98.7
108.1
113
121.2
123.2
125.6
7%
50Share-based compensation expense
14.2
15.3
16.6
17.6
18.3
18.7
19.6
19.7
17.9
20
22.5
4.7%
51Changes in working capital and other assets
(4.2)
(25.4)
47.6
(49.9)
(64.6)
4.6
12.2
(146.1)
38
(38)
(61.5)
30.8%
52Net cash flows from operating activities
426.9
443.1
516.3
565
603.5
724.7
908.8
859.1
965.9
968.3
955.8
8.4%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(82.5)
(124)
(127.4)
(142.7)
(97.3)
(92.5)
(107.6)
(121.2)
(105.3)
(103.9)
(107.1)
2.7%
54Purchases of investments / marketable securities
-
-
-
-
-
-
-
-
-
-
-
-
55Proceeds from maturities of marketable securities
-
-
-
-
-
-
-
-
-
-
-
-
56Other investing activities
(18.2)
(107.5)
(89.9)
3.8
(1.7)
(7.9)
(206.5)
(18.2)
(26.4)
(15.6)
(86.7)
16.9%
57Net cash flows from investing activities
(100.8)
(231.5)
(217.3)
(138.9)
(99.1)
(100.4)
(314.1)
(139.4)
(131.7)
(119.5)
(193.9)
6.8%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(495)
(500)
(400)
(475)
(775)
(775)
(1,000)
(1,100)
(900)
(850)
(767.7)
4.5%
59Dividends paid, net
-
-
-
-
-
-
-
-
-
-
-
-
60Debt issuance (repayments), net
147.4
311.6
59
64.3
258.3
5.2
392
359.9
29.8
(18.7)
21.5
(17.5)%
61Other financing activities
40.5
42.5
21.4
22.7
39.3
25.9
17.5
24.1
10.6
12.7
(8.9)
-
62Net cash flows from financing activities
(307)
(145.9)
(319.5)
(388)
(477.4)
(743.9)
(590.5)
(716)
(859.6)
(856)
(755.2)
9.4%
63Increase (decrease) in cash and cash equivalents
13.6
59.8
(10)
29.4
29.7
(113.5)
4.3
(2.6)
(26.2)
(10.4)
7.5
(5.8)%
64Cash and equivalents, ending balance
98.9
158.7
148.7
178.1
207.8
94.3
98.6
96
69.8
59.4
66.9
(3.8)%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
344.4
319.1
388.9
422.3
506.1
632.2
801.2
737.8
860.6
864.4
848.6
9.4%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Mettler Toledo (MTD) financial statements and performance

Explore Mettler Toledo (MTD) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.